Differential <i>Ang1</i> and <i>Ang4</i> mRNA expression following AOM-DSS exposure. by Alexander Hu (14755811)

Subjects:

Fig 5 - by Anni Koskinen (10133209)

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

“…After exposure to F-53B at 2, 10, and 50 ng/L, C. elegans showed an aging phenomenon as lipofuscin was significantly increased by 48.7–57.5% and locomotion, such as center point speed, was significantly decreased in all exposure groups. …”

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

“…After exposure to F-53B at 2, 10, and 50 ng/L, C. elegans showed an aging phenomenon as lipofuscin was significantly increased by 48.7–57.5% and locomotion, such as center point speed, was significantly decreased in all exposure groups. …”

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

“…After exposure to F-53B at 2, 10, and 50 ng/L, C. elegans showed an aging phenomenon as lipofuscin was significantly increased by 48.7–57.5% and locomotion, such as center point speed, was significantly decreased in all exposure groups. …”

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

“…After exposure to F-53B at 2, 10, and 50 ng/L, C. elegans showed an aging phenomenon as lipofuscin was significantly increased by 48.7–57.5% and locomotion, such as center point speed, was significantly decreased in all exposure groups. …”

Fig 5 - by Sang Tae Kim (6017996)

Plasma IgG concentrations to V1V2 antigens associated with RV144 vaccine efficacy. by LaTonya D. Williams (3140490)

Number of cases of syphilis in Japan: 2018–2022. by Akira Komori (8284599)

Subjects:

Genes showing 1.5 fold expression decrease in D381 relative to heterozygous <i>TOR1/tor1</i>. by Wanjun Qi (5571359)

A summary of calibration standards (n = 3). by Ewa Paszkowska (21246702)

Subjects:

Changes in body weight, fat mass and lean body mass over 5 years after RYGB independent of intervention groups. by Alice Bellicha (3583493)

Experimental scene in lightroom (measurement with a binocular open auto refractometer). by Tatsuya Iizuka (1927345)

Subjects:

PRISMA flow diagram. by Lukas E. Brümmer (11269299)

Subjects:

Fig 2 - by Lukas E. Brümmer (11269299)

Subjects:

Summary of tests. by Lukas E. Brümmer (11269299)

Subjects:

Overall and sensitivity analysis. by Lukas E. Brümmer (11269299)

Subjects:

Test specific IFU analysis. by Lukas E. Brümmer (11269299)

Subjects:

Tests analyzed descriptively not included in meta-analysis. by Lukas E. Brümmer (11269299)

Subjects:

List of parameters extracted from studies. by Lukas E. Brümmer (11269299)

Subjects: